星空体育官方入口网站网址大全-登录入口官网

#肝癌治疗#

39篇内容 | 1097人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2037355, encodeId=e9e3203e3557c, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=手术是肝癌治疗的首选手段！早期、中期、晚期肝癌患者均可获益, objectType=article, longId=738240, objectId=954ae38240b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=954ae38240b3, replyNumber=0, likeNumber=81, createdTime=2023-05-01, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=954ae38240b3, moduleTitle=手术是肝癌治疗的首选手段！早期、中期、晚期肝癌患者均可获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=954ae38240b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037353, encodeId=fba1203e35374, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=手术仍然是肝癌治疗的主要手段，中晚期肝癌、巨块型肝癌均可因手术获益！, objectType=article, longId=733738, objectId=2525e3373897, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2525e3373897, replyNumber=0, likeNumber=87, createdTime=2022-10-01, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2525e3373897, moduleTitle=手术仍然是肝癌治疗的主要手段，中晚期肝癌、巨块型肝癌均可因手术获益！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2525e3373897)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037350, encodeId=df6b203e35037, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=肝癌晚期肺转移，原发灶两年了还是不错，但肺部结节一直增大，多种靶向药控制不住，那么应该按照肝癌治疗还是肺癌？, objectType=article, longId=293693, objectId=6bb9293693a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bb9293693a0, replyNumber=0, likeNumber=49, createdTime=2022-03-11, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bb9293693a0, moduleTitle=肝癌晚期肺转移，原发灶两年了还是不错，但肺部结节一直增大，多种靶向药控制不住，那么应该按照肝癌治疗还是肺癌？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6bb9293693a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037354, encodeId=4de7203e35465, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=NCCN肝癌治疗临床指南前沿方案调整解析！新治疗方案生存率如何？, objectType=article, longId=731879, objectId=ad8de31879a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad8de31879a3, replyNumber=0, likeNumber=85, createdTime=2023-01-16, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad8de31879a3, moduleTitle=NCCN肝癌治疗临床指南前沿方案调整解析！新治疗方案生存率如何？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ad8de31879a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037352, encodeId=0df4203e352b6, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=NMPA批准中药一类新药淫羊藿素（阿可拉定）软胶囊用于肝癌治疗，华东医药获推广权, objectType=article, longId=294113, objectId=9c492941132f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c492941132f, replyNumber=0, likeNumber=77, createdTime=2023-01-01, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c492941132f, moduleTitle=NMPA批准中药一类新药淫羊藿素（阿可拉定）软胶囊用于肝癌治疗，华东医药获推广权, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9c492941132f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037351, encodeId=7433203e351e7, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=陈敏山教授：2021年肝癌治疗进展年度盘点, objectType=article, longId=293802, objectId=7ae3293802e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ae3293802e0, replyNumber=0, likeNumber=73, createdTime=2022-02-08, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ae3293802e0, moduleTitle=陈敏山教授：2021年肝癌治疗进展年度盘点, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7ae3293802e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037349, encodeId=50df203e349e8, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=针灸疗法在原发性肝癌治疗中的应用, objectType=article, longId=220672, objectId=5ca12206e2fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ca12206e2fb, replyNumber=0, likeNumber=64, createdTime=2021-11-27, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ca12206e2fb, moduleTitle=针灸疗法在原发性肝癌治疗中的应用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5ca12206e2fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037348, encodeId=ea62203e348a5, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=免疫联合靶向方案用于肝癌转化治疗专家共识发布，助力肝癌治疗突破, objectType=article, longId=213677, objectId=e6b52136e7d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6b52136e7d0, replyNumber=0, likeNumber=71, createdTime=2022-05-20, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6b52136e7d0, moduleTitle=免疫联合靶向方案用于肝癌转化治疗专家共识发布，助力肝癌治疗突破, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e6b52136e7d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037347, encodeId=5e1c203e3479d, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=Gut：肝癌治疗后抗丙肝病毒治疗可预防肝癌复发吗？, objectType=article, longId=208890, objectId=b5a5208890bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5a5208890bb, replyNumber=0, likeNumber=51, createdTime=2021-04-05, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5a5208890bb, moduleTitle=Gut：肝癌治疗后抗丙肝病毒治疗可预防肝癌复发吗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b5a5208890bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037346, encodeId=03c8203e34629, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=陈敏山教授：2020年度肝癌治疗进展年度盘点, objectType=article, longId=205913, objectId=8eea20591354, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eea20591354, replyNumber=0, likeNumber=83, createdTime=2021-10-12, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eea20591354, moduleTitle=陈敏山教授：2020年度肝癌治疗进展年度盘点, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8eea20591354)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037345, encodeId=a415203e34519, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=“癌症之王”肝癌治疗获十年以来重大突破, objectType=article, longId=201351, objectId=a5de2013518b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5de2013518b, replyNumber=0, likeNumber=50, createdTime=2021-08-20, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5de2013518b, moduleTitle=“癌症之王”肝癌治疗获十年以来重大突破, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a5de2013518b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037344, encodeId=bf8d203e344fe, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=Cell Death Dis：ZNF703可作为肝癌治疗靶点，其表达水平可预测患者对索拉非尼的敏感性性, objectType=article, longId=192541, objectId=92fe192541f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92fe192541f8, replyNumber=0, likeNumber=60, createdTime=2020-12-04, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92fe192541f8, moduleTitle=Cell Death Dis：ZNF703可作为肝癌治疗靶点，其表达水平可预测患者对索拉非尼的敏感性性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=92fe192541f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037342, encodeId=3752203e342e3, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=Nature：仁济医院“更聪明”肝癌治疗策略先让癌细胞衰老再给予精准清除, objectType=article, longId=180629, objectId=e22b18062944, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e22b18062944, replyNumber=0, likeNumber=62, createdTime=2019-10-29, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e22b18062944, moduleTitle=Nature：仁济医院“更聪明”肝癌治疗策略先让癌细胞衰老再给予精准清除, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e22b18062944)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037343, encodeId=0cba203e343b3, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=陈敏山：2019年原发性肝癌治疗进展盘点, objectType=article, longId=185732, objectId=ff9c185e32a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff9c185e32a3, replyNumber=0, likeNumber=56, createdTime=2020-04-10, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff9c185e32a3, moduleTitle=陈敏山：2019年原发性肝癌治疗进展盘点, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ff9c185e32a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037339, encodeId=94c1203e33965, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=ASCO肝癌治疗进展：O药联合伊匹木单抗客观缓解率31%, objectType=article, longId=167691, objectId=56da16e69151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56da16e69151, replyNumber=0, likeNumber=56, createdTime=2019-07-12, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56da16e69151, moduleTitle=ASCO肝癌治疗进展：O药联合伊匹木单抗客观缓解率31%, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=56da16e69151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037340, encodeId=a9de203e34058, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=肝癌治疗新进展：仑伐替尼+K药有望登顶肝细胞癌一线治疗, objectType=article, longId=177332, objectId=003a1e733254, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=003a1e733254, replyNumber=0, likeNumber=58, createdTime=2019-08-14, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=003a1e733254, moduleTitle=肝癌治疗新进展：仑伐替尼+K药有望登顶肝细胞癌一线治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=003a1e733254)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037341, encodeId=47ca203e34145, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=2019 ESMO |TKI治疗论坛：中外大咖台论道，引领肠癌、肝癌治疗新理念, objectType=article, longId=180454, objectId=2c23180454c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c23180454c6, replyNumber=0, likeNumber=84, createdTime=2020-01-26, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c23180454c6, moduleTitle=2019 ESMO |TKI治疗论坛：中外大咖台论道，引领肠癌、肝癌治疗新理念, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2c23180454c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037338, encodeId=e53c203e33886, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=邢宝才教授：局部联合全身系统性治疗是肝癌治疗的大势所趋, objectType=article, longId=167121, objectId=464716e121c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=464716e121c2, replyNumber=0, likeNumber=79, createdTime=2019-12-11, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=464716e121c2, moduleTitle=邢宝才教授：局部联合全身系统性治疗是肝癌治疗的大势所趋, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=464716e121c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037336, encodeId=0ae0203e336cf, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=秦叔逵教授：肝癌大国的PD-1之路，看免疫疗法如何破冰晚期肝癌治疗!, objectType=article, longId=156744, objectId=9b42156e4404, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b42156e4404, replyNumber=0, likeNumber=71, createdTime=2019-02-05, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b42156e4404, moduleTitle=秦叔逵教授：肝癌大国的PD-1之路，看免疫疗法如何破冰晚期肝癌治疗!, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9b42156e4404)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2037335, encodeId=b25c203e335c7, content=<a href='/topic/show?id=c19381284ca' target=_blank style='color:#2F92EE;'>#肝癌治疗#</a>, objectTitle=抗击肝癌治疗“寒冬僵局” 中国肝癌患者将迎治疗春天, objectType=article, longId=156634, objectId=d1af15663476, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1af15663476, replyNumber=0, likeNumber=54, createdTime=2019-05-15, rootId=0, userName=ms3117646317107274, userId=97862500016, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1af15663476, moduleTitle=抗击肝癌治疗“寒冬僵局” 中国肝癌患者将迎治疗春天, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d1af15663476)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肝癌治疗

2020-05-29

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

手术是肝癌治疗的首选手段！早期、中期、晚期肝癌患者均可获益

2023-05-01

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

手术仍然是肝癌治疗的主要手段，中晚期肝癌、巨块型肝癌均可因手术获益！

2022-10-01

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

肝癌晚期肺转移，原发灶两年了还是不错，但肺部结节一直增大，多种靶向药控制不住，那么应该按照肝癌治疗还是肺癌？

2022-03-11

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

NCCN肝癌治疗临床指南前沿方案调整解析！新治疗方案生存率如何？

2023-01-16

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

NMPA批准中药一类新药淫羊藿素（阿可拉定）软胶囊用于肝癌治疗，华东医药获推广权

2023-01-01

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

陈敏山教授：2021年肝癌治疗进展年度盘点

2022-02-08

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

针灸疗法在原发性肝癌治疗中的应用

2021-11-27

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

免疫联合靶向方案用于肝癌转化治疗专家共识发布，助力肝癌治疗突破

2022-05-20

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

Gut：肝癌治疗后抗丙肝病毒治疗可预防肝癌复发吗？

2021-04-05

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

陈敏山教授：2020年度肝癌治疗进展年度盘点

2021-10-12

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

“癌症之王”肝癌治疗获十年以来重大突破

2021-08-20

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

Cell Death Dis：ZNF703可作为肝癌治疗靶点，其表达水平可预测患者对索拉非尼的敏感性性

2020-12-04

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

Nature：仁济医院“更聪明”肝癌治疗策略先让癌细胞衰老再给予精准清除

2019-10-29

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

陈敏山：2019年原发性肝癌治疗进展盘点

2020-04-10

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

ASCO肝癌治疗进展：O药联合伊匹木单抗客观缓解率31%

2019-07-12

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

肝癌治疗新进展：仑伐替尼+K药有望登顶肝细胞癌一线治疗

2019-08-14

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

2019 ESMO |TKI治疗论坛：中外大咖台论道，引领肠癌、肝癌治疗新理念

2020-01-26

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

邢宝才教授：局部联合全身系统性治疗是肝癌治疗的大势所趋

2019-12-11

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

秦叔逵教授：肝癌大国的PD-1之路，看免疫疗法如何破冰晚期肝癌治疗!

2019-02-05

ms3117646317107274 (审核中...)

前往app查看评论内容

#肝癌治疗#

抗击肝癌治疗“寒冬僵局” 中国肝癌患者将迎治疗春天

2019-05-15

科室
- - 订阅+
  - 更多科室
工具
服务